More than two decades since the discovery of the human immunodeficiency virus (HIV), the aetiological agent of AIDS, the pandemic continues to expand. The predictable clinical course of the illness is characterized by an initial symptomatic disease that mimics infectious mononucleosis, followed by an asymptomatic period of approximately 8-10 years in untreated persons, during which time there is ongoing viral replication and progressive loss of CD4 + T-lymphocytes. Most antiretroviral (ARV) naive individuals eventually develop immunodeficiency and die from AIDS-related complications, with time to death being~10 years after becoming infected. The vast majority of ARV naive individuals exhibit evidence of ongoing viral replication and progressive CD4 + T-lymphocyte depletion. However, a small proportion of infected subjects (5-15 %) remain clinically and/or immunologically stable for years. These persons remain AIDS free in spite of years of HIV infection and are referred to as 'long-term non-progressors' (LTNPs) (Cao et al., 1995; Munoz et al., 1995; Pantaleo et al., 1995) . LTNPs are characterized by documented HIV infection for over 7 years, a stable CD4 + T-lymphocyte count over time and .600 T-lymphocyte cells ml 21 , low levels of cell-free virus in peripheral blood, no symptoms or signs of HIV-induced immunosuppression and no history of ARV therapy (Sheppard et al.,1993; Lifson et al., 1991; Levy, 1993) . These subjects with greater immune control can serve as better models for studying the role of host factors in HIV infection. However, inter-individual variability and other existing cofactors warrant intensive and long-term research in order to identify LTNPs among the general HIV-infected population.
The AIDS pandemic is particularly serious in India, where HIV-1 clade C is widely distributed (Sheppard et al., 1993 The criteria used to define nonprogression included individuals with a CD4 + T-lymphocyte count of .400 cells ml 21 for .7 years, asymptomatic and ARV naive (Sheppard et al., 1993; Lifson et al., 1991; Levy, 1993 after 5 years of HIV-1 infection (Sheppard et al., 1993) .
Routine microbiological and clinical investigations were carried out using standard laboratory methods. CD4
+ T-lymphocyte profile and plasma viral load (PVL) were determined using a FACSCount flow cytometry assay (Becton Dickinson) and a PVL (COBAS-Amplicor) analyser, respectively. Haemoglobin levels were estimated using the three-part Sysmex-K21 haemato-analyser (Kobe). Statistical analysis was done using the Statistical Package for Social Sciences software, version 13.0 (SPSS).
The demographic details, and clinical and laboratory characteristics of the study groups are presented in Table 1 (Pirzada et al., 2006) . The PVL details suggest that LTNPs have better immune control over HIV viral replication than other HIV-infected subjects (Sheppard et al., 1993; Lifson et al., 1991; Levy, 1993) . The criteria defining LTNPs may vary with the geographical locality and should be adapted based on the pattern of disease progression, as a substantial variation in the rates of disease progression has been observed across countries (Kumarasamy et al., 2003; Hira et al., 2003; Rutherford et al., 1990 
